Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria
Obesity is one of the leading and the most serious risk factors of cardiovascular diseases. Overweight provokes many metabolic and hemodynamic disorders. About 30% of inhabitants of the planet have overweight and prevalence of obesity increases by 10% every 10 years according to the WHO data. The...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2018-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227672096342016 |
|---|---|
| author | Yu. N. Belenkov E. V. Privalova V. Y. Kaplunova V. Y. Zektser N. N. Vinogradova I. S. Ilgisonis G. A. Shakaryants M. V. Kozhevnikova A. S. Lishuta |
| author_facet | Yu. N. Belenkov E. V. Privalova V. Y. Kaplunova V. Y. Zektser N. N. Vinogradova I. S. Ilgisonis G. A. Shakaryants M. V. Kozhevnikova A. S. Lishuta |
| author_sort | Yu. N. Belenkov |
| collection | DOAJ |
| description | Obesity is one of the leading and the most serious risk factors of cardiovascular diseases. Overweight provokes many metabolic and hemodynamic disorders. About 30% of inhabitants of the planet have overweight and prevalence of obesity increases by 10% every 10 years according to the WHO data. The probability of arterial hypertension in obese patients is 50% higher than in people with normal body mass. Framingham study showed that obesity is an independent, significant risk factor of ischemic heart disease, myocardial infarction, cerebral stroke and diabetes mellitus. The most dangerous is the central obesity with the preferential fat deposition in the abdomen. Combination of visceral obesity, violation of carbohydrate and lipid metabolism, arterial hypertension, and close pathogenic relationship between these factors underlie the isolated symptom complex known as metabolic syndrome. J. Vague was the first to describe relationship between abdominal obesity with cardiovascular disease and mortality in 1947. In our country G.F. Lang noticed common combination of arterial hypertension with obesity, lipid and carbohydrate metabolism disorders. Thus, metabolic syndrome significantly increases risk and severity of cardiovascular disease. Within last decades criteria of metabolic syndrome stays constant. The factors of insulin resistance and endothelial dysfunction as stages of the pathogenesis of the metabolic syndrome have been studied in detail. The mechanisms of insulin resistance and endothelial dysfunction are discussed in detail in this article as well as inflammatory markers and the significance of highly sensitive C-reactive protein. |
| format | Article |
| id | doaj-art-a2678771da9b4894a1eb1dc5551db2f1 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2018-11-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-a2678771da9b4894a1eb1dc5551db2f12025-08-23T10:00:30ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532018-11-0114575776410.20996/1819-6446-2018-14-5-757-7641534Metabolic Syndrome: Development of the Issue, Main Diagnostic CriteriaYu. N. Belenkov0E. V. Privalova1V. Y. Kaplunova2V. Y. Zektser3N. N. Vinogradova4I. S. Ilgisonis5G. A. Shakaryants6M. V. Kozhevnikova7A. S. Lishuta8I.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)City Clinical Hospital named after A.K. YeramishantsevI.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)Obesity is one of the leading and the most serious risk factors of cardiovascular diseases. Overweight provokes many metabolic and hemodynamic disorders. About 30% of inhabitants of the planet have overweight and prevalence of obesity increases by 10% every 10 years according to the WHO data. The probability of arterial hypertension in obese patients is 50% higher than in people with normal body mass. Framingham study showed that obesity is an independent, significant risk factor of ischemic heart disease, myocardial infarction, cerebral stroke and diabetes mellitus. The most dangerous is the central obesity with the preferential fat deposition in the abdomen. Combination of visceral obesity, violation of carbohydrate and lipid metabolism, arterial hypertension, and close pathogenic relationship between these factors underlie the isolated symptom complex known as metabolic syndrome. J. Vague was the first to describe relationship between abdominal obesity with cardiovascular disease and mortality in 1947. In our country G.F. Lang noticed common combination of arterial hypertension with obesity, lipid and carbohydrate metabolism disorders. Thus, metabolic syndrome significantly increases risk and severity of cardiovascular disease. Within last decades criteria of metabolic syndrome stays constant. The factors of insulin resistance and endothelial dysfunction as stages of the pathogenesis of the metabolic syndrome have been studied in detail. The mechanisms of insulin resistance and endothelial dysfunction are discussed in detail in this article as well as inflammatory markers and the significance of highly sensitive C-reactive protein.https://www.rpcardio.online/jour/article/view/1766metabolic syndromeobesitycardiovascular diseasesc-reactive protein |
| spellingShingle | Yu. N. Belenkov E. V. Privalova V. Y. Kaplunova V. Y. Zektser N. N. Vinogradova I. S. Ilgisonis G. A. Shakaryants M. V. Kozhevnikova A. S. Lishuta Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria Рациональная фармакотерапия в кардиологии metabolic syndrome obesity cardiovascular diseases c-reactive protein |
| title | Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria |
| title_full | Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria |
| title_fullStr | Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria |
| title_full_unstemmed | Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria |
| title_short | Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria |
| title_sort | metabolic syndrome development of the issue main diagnostic criteria |
| topic | metabolic syndrome obesity cardiovascular diseases c-reactive protein |
| url | https://www.rpcardio.online/jour/article/view/1766 |
| work_keys_str_mv | AT yunbelenkov metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria AT evprivalova metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria AT vykaplunova metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria AT vyzektser metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria AT nnvinogradova metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria AT isilgisonis metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria AT gashakaryants metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria AT mvkozhevnikova metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria AT aslishuta metabolicsyndromedevelopmentoftheissuemaindiagnosticcriteria |